SPX Gestao de Recursos Ltda Makes New $491,000 Investment in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)

SPX Gestao de Recursos Ltda acquired a new position in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNAFree Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 50,000 shares of the company’s stock, valued at approximately $491,000. SPX Gestao de Recursos Ltda owned about 0.09% of Ginkgo Bioworks as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in DNA. SBI Securities Co. Ltd. bought a new stake in Ginkgo Bioworks during the 4th quarter worth about $29,000. KBC Group NV bought a new stake in Ginkgo Bioworks during the 4th quarter worth about $31,000. Palumbo Wealth Management LLC bought a new position in shares of Ginkgo Bioworks in the 4th quarter valued at about $144,000. Y Intercept Hong Kong Ltd bought a new position in shares of Ginkgo Bioworks in the 4th quarter valued at about $154,000. Finally, SVB Wealth LLC bought a new position in shares of Ginkgo Bioworks in the 4th quarter valued at about $171,000. Institutional investors own 78.63% of the company’s stock.

Ginkgo Bioworks Trading Down 7.9 %

Shares of NYSE DNA opened at $6.95 on Tuesday. The firm has a market capitalization of $403.05 million, a PE ratio of -0.53 and a beta of 1.23. Ginkgo Bioworks Holdings, Inc. has a 1 year low of $5.26 and a 1 year high of $50.40. The firm’s 50-day moving average is $11.32 and its 200-day moving average is $9.23.

Ginkgo Bioworks Profile

(Free Report)

Ginkgo Bioworks Holdings, Inc, together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.

Read More

Institutional Ownership by Quarter for Ginkgo Bioworks (NYSE:DNA)

Receive News & Ratings for Ginkgo Bioworks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ginkgo Bioworks and related companies with MarketBeat.com's FREE daily email newsletter.